Re: Glycolate Oxidase is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.
Publication
, Journal Article
Assimos, DG
Published in: J Urol
July 2016
Duke Scholars
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
July 2016
Volume
196
Issue
1
Start / End Page
281 / 282
Location
United States
Related Subject Headings
- Urology & Nephrology
- Mice
- Hyperoxaluria, Primary
- Hyperoxaluria
- Disease Models, Animal
- Animals
- Alcohol Oxidoreductases
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Assimos, D. G. (2016). Re: Glycolate Oxidase is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I. J Urol, 196(1), 281–282. https://doi.org/10.1016/j.juro.2016.04.005
Assimos, Dean G. “Re: Glycolate Oxidase is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.” J Urol 196, no. 1 (July 2016): 281–82. https://doi.org/10.1016/j.juro.2016.04.005.
Assimos DG. Re: Glycolate Oxidase is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I. J Urol. 2016 Jul;196(1):281–2.
Assimos, Dean G. “Re: Glycolate Oxidase is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.” J Urol, vol. 196, no. 1, July 2016, pp. 281–82. Pubmed, doi:10.1016/j.juro.2016.04.005.
Assimos DG. Re: Glycolate Oxidase is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I. J Urol. 2016 Jul;196(1):281–282.
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
July 2016
Volume
196
Issue
1
Start / End Page
281 / 282
Location
United States
Related Subject Headings
- Urology & Nephrology
- Mice
- Hyperoxaluria, Primary
- Hyperoxaluria
- Disease Models, Animal
- Animals
- Alcohol Oxidoreductases
- 3202 Clinical sciences
- 1103 Clinical Sciences